Tag
COVID‑19
- Medical sector drives rising adoption of breath analyzers: Fortune Business Insights
- New Nova Scotia lung clinic aims to slash years-long waits for breathing tests
- U.S. tariffs on Chinese medical devices threaten global supply chains
- Regeneron Pharmaceuticals gets access to biometric data for 15 million people
- Complete Solar Holdings shares climb 38% after SunPower Corporation acquisition
- Datametrex AI subsidiary Medi-Call partners with Lucira Health for telehealth services
- Lam Research completes acquisition of semiconductor equipment distributor
- The Mugglehead technology roundup: medical tech and biotechnology edition
- ATMA receives Health Canada approval for new psilocybin trial
- Cue Health rolls out COVID‑19 all‑in‑one app
- United States takes aim at microchip shortage
- Choom granted creditor protection, interim financing from Aurora
- Pandemic not responsible for rising pot sales in Canada: study
- Choom posts $5.9M net loss after 'challenging' Q2
- Tetra Bio‑Pharma to receive $4.5M loan from Quebec government
- Clinical trial in UK to look at medical cannabis as treatment for long Covid
- Quebec will require vaccine passports to buy cannabis and alcohol
- Ontario pitches permanent weed delivery and curbside pickup
- 15% of remote employees worked high during the pandemic: survey
- Washington state latest to join ‘Joints for Jabs’ campaign
- More Canadians, Americans open to psychedelic therapy, surveys show
- Aurora stock falls amid more large losses and cost cuts
- Canadian cannabis sales remain steady in February at $263M
- 4/20 weed sales rebound 8% in North America
- Weed use up 43% since legalization: StatsCan
- Pot product manufacturer Valens bounces back in Q1
- Aphria blames slump on Covid despite steady market growth
- Weed impedes entry of Covid‑19 into cells: study
- Canadian cannabis sales dip to $261M in November
- Virginia set to be first Southern state to legalize adult‑use cannabis
- Organigram shares sink as sales shrink
- 2020 in review: Cannabis and Covid‑19
- Canadian cannabis sales climb to $270M in October
- Remove OCS advantages to increase Ontario's legal market share, pot shops say
- Health Canada requests public feedback on amending various strict pot rules
- MediPharm reports 89% one‑year revenue decline
- Ontario boosts Canadian cannabis sales to $245M in August
- Aphria shares tank on weak international sales
- Ottawa pot shop chain unveils Canada's first AI budtender
- Neptune Wellness pivots further into CPG with Kraft Heinz deal
- Marigolds Cannabis pays homage to legalization and friendship
- US House keeps cannabis banking provisions in latest Covid relief bill
- Fire & Flower's revenues rise as retail battle heats up
- Charlotte's Web continues B2B decrease dulled by e‑commerce gains
- 'Historic' US House vote this month opens a door toward legalization
- Ikänik Farms‑led study suggests cannabis oil slows coronavirus replication
- Inner Spirit's retail franchise model nets first EBITDA profit
- Cresco Labs' Illinois stronghold pushes revenues up 42%
- June Canadian weed retail sales break $200M mark
- Curaleaf reports strong revenue growth despite pandemic setbacks